"This board will play an important role in ensuring that our nation is well-prepared to prevent and respond to public health emergencies," Leavitt said. "The members' depth of expertise will be invaluable as we continue to prepare."
Authorized by the Pandemic and All-Hazards Preparedness Act, the board is holding its first meeting today and tomorrow in Washington. Members of the National Biodefense Science Board are:
- Patricia Quinlisk, M.D., M.P.H., Chair
- Ruth L. Berkelman, M.D.
- Stephen V. Cantrill, M.D.
- Roberta Carlin, M.S., J.D.
- Albert J. Di Rienzo
- Kenneth L. Dretchen, Ph.D.
- John D. Grabenstein, R.Ph., Ph.D.
- James J. James, Brigadier General (Retired), M.D., Dr.PH., M.H.A.
- Thomas J. MacVittie, Ph.D.
- John S. Parker, M.D., Major General (Retired)
- Andrew T. Pavia, M.D.
- Eric A. Rose, M.D.
- Patrick J. Scannon, M.D., Ph.D.